BioConsortia, Inc.’s Post

BioConsortia CEO Marcus Meadows-Smith shares insights in S&P Global's 2024 Biologicals Review. He discusses our upcoming launches, including Amara (foliar fungicide) and Always N (nitrogen-fixing seed treatment), and highlights the performance of Solvarix (bionematicide). Learn more about how BioConsortia’s microbial innovations are shaping the future of agricultural biologicals. Read the full interview here: https://lnkd.in/gu4KWtes #Biologicals #CropProtection #NitrogenFixation #BioConsortia #UnleashThePowerOfMicrobes

BioConsortia Interview: Next gen biologicals will outcompete synthetic CP - BioConsortia

BioConsortia Interview: Next gen biologicals will outcompete synthetic CP - BioConsortia

https://bioconsortia.com

To view or add a comment, sign in

Explore topics